Quantitative and qualitative lipid improvement with chronic hepatitis C virus eradication using direct-acting antivirals.

Satoru JoshitaYuki YamashitaToru OkamotoYoko UsamiAyumi SugiuraTomoo YamazakiAkemi KakinoMasao OtaTatsuya SawamuraTakeji Umemura

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2021)

HCV eradication by direct-acting antivirals may produce quantitative lipid profile changes, along with PCSK9 production recovery in addition to qualitative lipid improvement, which possibly confers the additional secondary benefits of atherosclerosis improvement and cardiovascular disease event reduction.

Keyphrases

hepatitis c virus
cardiovascular disease
human immunodeficiency virus
helicobacter pylori infection
high resolution
systematic review
fatty acid
type diabetes
coronary artery disease
metabolic syndrome
mass spectrometry
helicobacter pylori